Savara Inc — Director's Dealing 2010

Jul 2, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADVENTRX PHARMACEUTICALS INC (ANX)
CIK: 0001160308
Period of Report: 2010-06-30

Reporting Person: LIEF JACK (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-06-30	Stock Option (Right to Buy)	$1.63	A	4000	Acquired	2020-06-30	Common Stock (4000)	Direct

Footnotes

F1: This option vests and becomes exercisable in 12 substantially equal monthly installments over the 12-month period following the date of grant, with the first such vesting date being July 30, 2010.